Evaluation of Exosomes Injection in Treatment of Male Androgenetic Alopecia: Clinical and Immunohistochemical Study

Not Applicable

Not yet recruiting

• Conditions: Androgenetic Alopecia
• Interventions: Drug: Plasma derived exosomes

• Registration Number: NCT07112586
• Lead Sponsor: Ain Shams University

Brief Summary

Intradermal injection of exosomes in treatment of male androgenetic alopecia, clinically and using a immunohistochemical marker

Detailed Description

Not available

Study Timeline

• Status Verified: 2025-08
• Study First Submitted: 2025-08-01
• Study First Submitted QC: 2025-08-01
• Last Update Submitted: 2025-08-01
• Study First Posted: 2025-08-08
• Last Update Posted: 2025-08-08
• Study Start: 2025-08-30
• Primary Completion: 2026-01-31
• Study Completion: 2027-01-31

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: Male
• Target Recruitment: 15

Inclusion Criteria

• Androgenetic Alopecia Grades 1-4

Exclusion Criteria

• blood diseases Receiving other treatments History of malignancy or allergic reaction to exosomes

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Males 18-40 years old with androgenetic alopecia	Plasma derived exosomes	Males with androgenetic alopecia willing to do mesotherapy sessions

Primary Outcome Measures

Name	Time	Method
Terminal to vellus hair ratio improvement	One year	Counting the terminal and vellus hair counts and calculating the ratio, and comparing it between different study sessions and at follow-ups

Trial Locations

Locations (1)

Ain Shams Univeristy Faculty of medicine; 🇪🇬 Cairo, Abbasia, Egypt